ScreenerHero

GLAS Glass House Brands Inc.

Partial data
AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · glasshousebrands.com
7.970USD-0.75%Mkt Cap: 748.29M $P/E: —

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packa…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap748.29M USD
Enterprise Value897.38M USD
Revenue (TTM)176.98M USD
Gross Profit76.96M USD
Net Income (TTM)-29.66M USD
Revenue/Share2.07 USD
Last Price7.970 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees357
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)35.42
PEG—
EV/EBITDA-37.06
EV/Revenue5.07
P/S4.24
P/B9.77
EPS (TTM)-0.80
EPS (Forward)0.23
52W Range
5.15032% of range13.93
52W High13.93 USD
52W Low5.150 USD
Profitability
Gross Margin42.29%
Oper. Margin-6.37%
EBITDA Margin-13.68%
Profit Margin-16.30%
ROE-40.11%
ROA-9.31%
Growth
Revenue Growth-1.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF11.45M USD
CapEx (TTM)27.18M USD
FCF Margin-11.18%
FCF Yield-2.64%
Net Debt53.76M USD
Net Debt/EBITDA-2.22
Balance Sheet
Debt/Equity1.01
Current Ratio1.33
Quick Ratio0.55
Book Value/Sh0.82 USD
Cash/Share0.20 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)16.00 USD
Upside (mean)+100.8%
Target Range15.00 USD – 17.00 USD
15.00+100.8% to mean17.00
# Analysts3
Ownership
Shares Out.88.00M
Float73.91M
Insiders7.56%
Institutions20.32%
Short Interest
Short Ratio0.5d
Short % Out.0.20%
Shares Short352.25K
Short (prev mo.)300.49K
Technical
SMA 509.613 (-17.1%)
SMA 2009.398 (-15.2%)
Beta0.63
S&P 52W Chg14.29%
Avg Vol (30d)418.01K
Avg Vol (10d)681.38K
Technical Indicators
RSI (14)32.2
MACD-0.6403
MACD Signal-0.4962
MACD Hist.-0.1441
BB Upper11.07 USD
BB Middle9.371 USD
BB Lower7.676 USD
BB Width36.18%
ATR (14)0.6133 USD
Vol Ratio (20d)1.21x